Expectations trend
FY2027 · fiscal year ending 2027-11-30 · fmp
Levi Strauss & Co (LEVI)
NYSEConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-11-04
$23.10-2.94%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.70 → 1.67 EPS · FY ending Nov 30, 2027 · 8 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 9 to 8; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LEVI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted diluted EPS between $1.42 and $1.48 | A primary condition in Levi Strauss & Co's published investment case. The stated target is >= $1.42 per share. | Intact | Adjusted diluted EPS falls below $1.42 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-11-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a consumer-brand business with an execution-led growth thesis, rather than a turnaround story. The 1-to-3-year thesis is intact, but the signal has softened from favorable to mildly favorable as company momentum declined.
The valuation evidence suggests LEVI is cheap versus peers, with the model labeling expectations as justified and finding little gap between expectations and its assessment. Fragility is low, so the evidence does not point to unusually concentrated expectations.
Near term, management is on track with its priorities: it raised full-year revenue, margin, and adjusted earnings guidance, and adjusted EBIT margin improved through 2026-Q3. However, recent momentum has weakened, and the snapshot flags declining earnings surprises despite low near-term miss risk.
The multi-year thesis depends on management sustaining revenue growth and margin expansion while maintaining credibility after raising guidance. Near term, a guidance reversal would hurt confidence, while continued strength or weakness from apparel-sector peers could support or weaken the sector backdrop.
Over the next 1 to 3 years, LEVI’s thesis rests on continued delivery against raised guidance, with a supportive valuation assessment but softer momentum and meaningful execution risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Levi Strauss & Co's published investment case. The stated target is No major disruptive departures or governance issues. |
| Intact |
| Significant unexpected management departures or governance issues arise |
No disruptive departures; routine CFO hire & director retirement CFO external hire and director age-based retirement are routine. No unexpected departures or governance crises detected. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Adjusted EBIT margin expands to approximately 12% | A primary condition in Levi Strauss & Co's published investment case. The stated target is >= 12%. | Under Pressure | Adjusted EBIT margin falls below 10% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Adjusted EBIT margin was 15.5% in Q3 2026 compared to 11.8% in Q3 2025.” “◦ The impact of tariff refunds contributed 490 basis points (1) of margin expansion, of which approximately 160 basis points (2) were redeployed to support the business.” Delivery assessment Nov 4, 2026 |
Full year 2026 net revenue between $5.5B and $6.5B | A primary condition in Levi Strauss & Co's published investment case. The stated target is >= $5.5 billion. | Intact | Full year revenue falls below $5.5 billion in FY26 | Revenue: $1.61B FY2026-Q3; GAAP. Published target: >= $5.5 billion. Annual target cannot be compared with a quarterly or TTM observation. Oct 7, 20261,609,700,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Financial Highlights for the Third Quarter • Net Revenues of $1.6 billion increased 4% on a reported basis and 5% on an organic basis versus Q3 2025.” “Guidance includes the impact of IEEPA tariff refunds of which the company is redeploying approximately $60 million for the full year, including approximately $35 million for the fourth quarter.” Revenue was $1.610 billion in 2026-Q3. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.71 → $1.67 · observed estimates
$7.08B → $7.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-25 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-26 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-27 | $1.71 | $7,084,842,203 | 9 / 10 |
| 2026-07-28 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-29 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-30 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-07-31 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-01 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-02 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-03 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-04 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-05 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-06 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-07 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-08 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-09 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-10 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-12 | $1.71 | $7,084,829,140 | 15 / 14 |
| 2026-08-13 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-14 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-15 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-16 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-17 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-18 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-19 | $1.71 | $7,084,841,939 | 9 / 10 |
| 2026-08-20 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-21 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-22 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-23 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-24 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-25 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-26 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-27 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-28 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-29 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-30 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-08-31 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-01 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-02 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-03 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-04 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-05 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-06 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-07 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-08 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-09 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-10 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-11 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-12 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-13 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-14 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-15 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-16 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-17 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-18 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-19 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-20 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-21 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-22 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-23 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-24 | $1.71 | $7,084,836,021 | 9 / 10 |
| 2026-09-25 | $1.71 | $7,086,004,079 | 9 / 10 |
| 2026-09-26 | $1.71 | $7,086,004,079 | 9 / 10 |
| 2026-09-27 | $1.71 | $7,086,004,079 | 9 / 10 |
| 2026-09-28 | $1.71 | $7,086,004,079 | 9 / 10 |
| 2026-09-29 | $1.71 | $7,086,004,079 | 9 / 10 |
| 2026-09-30 | $1.71 | $7,087,161,422 | 9 / 10 |
| 2026-10-01 | $1.71 | $7,086,326,208 | 9 / 10 |
| 2026-10-02 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-03 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-04 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-05 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-06 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-07 | $1.70 | $7,088,905,572 | 9 / 10 |
| 2026-10-08 | $1.70 | $7,072,115,786 | 9 / 10 |
| 2026-10-09 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-10 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-11 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-12 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-13 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-14 | $1.67 | $7,041,067,779 | 9 / 10 |
| 2026-10-15 | $1.67 | $7,041,996,350 | 9 / 10 |
| 2026-10-16 | $1.66 | $7,043,632,064 | 8 / 10 |
| 2026-10-17 | $1.66 | $7,043,632,064 | 8 / 10 |
| 2026-10-18 | $1.66 | $7,043,632,064 | 9 / 10 |
| 2026-10-19 | $1.66 | $7,043,632,064 | 9 / 10 |
| 2026-10-20 | $1.66 | $7,043,632,064 | 9 / 10 |
| 2026-10-21 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-22 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-23 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-24 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-25 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-26 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-27 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-28 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-29 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-30 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-10-31 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-11-01 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-11-02 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-11-03 | $1.67 | $7,046,989,686 | 8 / 10 |
| 2026-11-04 | $1.67 | $7,046,989,686 | 8 / 10 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 12 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 8 recorded
0 raises · 1 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.